Am J Transplant, Volume 19, Suppl 3 Archives - Page 177 of 214 - ATC Abstracts

2019 American Transplant Congress
The Impact of Transplant Hospital Organ Procurement on Medicare Cost Report Reimbursement
E. Y. Zavala¹, J. Rogers²
¹Transplant Center, Vanderbilt University Medical Center, Nashville, TN, ²Transplant Management Group, San Diego, CA
*Purpose: Medicare organ acquisition reimbursement from the Medicare Cost Report includes costs associated with transplant hospitals acquiring an organ for Medicare transplant patients and the…
2019 American Transplant Congress
Use of Marginal Liver Donors in Pediatric Transplantation: Diverse Profiles of Use in Major Transplant Centers
C. S. Hwang¹, A. Aqul², A. Mufti³, S. Hanish¹, D. Desai¹, P. Vagefi¹, M. MacConmara¹
¹Surgery, UT Southwestern, Dallas, TX, ²Pediatrics, UT Southwestern, Dallas, TX, ³Medicine, UT Southwestern, Dallas, TX
*Purpose: Pediatric liver transplantation is highly specialized only a small number of centers have consistent large volume experience. We tested the hypothesis that large volume…
2019 American Transplant Congress
Compatible Pairs in Paired Kidney Exchange – Are There Winners and Loosers?
V. Chipman¹, B. Lee¹, M. Cooper², M. C. Cuffy³, M. Ronin⁴, G. Hil⁴, S. Flechner⁵, A. Thomas⁶, D. A. Mandelbrot⁷, A. D. Waterman⁸, C. E. Freise¹, G. R. Roll¹
¹UCSF, San Francisco, CA, ²Georgetown Univ, Washington, DC, ³UC Hospital, Cincinnati, OH, ⁴NKR, Babylon, NY, ⁵Cleavland Clinic, Cleavland, OH, ⁶Johns Hopkins, Baltimore, MD, ⁷Univ of Wisconsin, Madison, WI, ⁸UCLA and Terasaki Research Institute, Los Angeles, CA
*Purpose: To understand patterns of participation for compatible pairs and their impact in increasing paired donation in a national registry.*Methods: Favorable pairs (FP) are defined…
2019 American Transplant Congress
Patient Centered AUC-Monitoring of Tacrolimus Using Capillary Microsampling
M. T. Gustavsen, K. Midtvedt, N. Vethe, S. Bergan, A. Åsberg
Oslo University Hospital, Rikshospitalet, Oslo, Norway
*Purpose: To reduce unwanted side effects of Tacrolimus (Tac), improvement of dosing is warranted. Therapeutic drug monitoring (TDM) of Tac based on trough concentrations (C0)…
2019 American Transplant Congress
Protocol Cardiac Cathaterization in Renal Transplant Candidates
D. B. Leeser¹, C. B. Stone², A. Maldonado², D. L. Morris³, K. L. McLawhorn², H. B. Jones²
¹Surgery, East Carolina Univ Sch of Med, Greenville, NC, ²Transplanation, Vidant Medical Center, Greenville, NC, ³Cardiology, East Carolina Univ Sch of Med, Greenville, NC
*Purpose: Appropriate cardiac evaluation prior to kidney transplantation is controversial. The following retrospective analysis was performed to evaluate the value of performing cardiac catheterization on…
2019 American Transplant Congress
Effect of ATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients
Y. Jiang, X. Zhang
Beijing Chao-yang Hospital, Beijing, China
*Purpose: Myeloid-derived suppressor cells (MDSCs) consist of heterogeneous myeloid progenitors and precursors that was first defined in cancer patients and are characterized by a immunoregulatory…
2019 American Transplant Congress
FcγRIIB is a Novel CD8⁺Effector T Cell Intrinsic Regulatory Pathway That Correlates with Freedom from Rejection in Renal Transplant Patients
A. B. Morris¹, D. F. Pinelli¹, D. Liu¹, J. M. Boss², C. D. Scharer², M. Fribourg³, P. Cravedi³, P. S. Heeger³, M. L. Ford¹
¹Surgery, Emory University, Atlanta, GA, ²Micro & Immuno, Emory University, Atlanta, GA, ³Center for Translational Transplant Research, Icahn SOM at Mount Sinai, New York, NY
*Purpose: To understand the functional role and clinical relevance of FcγRIIB on CD8+ T cells in transplantation.*Methods: See results*Results: FcγRIIB is the sole inhibitory Fcγ…
2019 American Transplant Congress
Renal Outcomes from Expander-1: Pilot Study of HCV+ Donor Kidneys for HCV- Kidney Recipients
S. Thaduri¹, C. Durand¹, N. Desai², D. Segev², N. Bair¹, D. Brown¹, F. F. Naqvi¹
¹Medicine, -Johns Hopkins University, -Baltimore, MD, ²Surgery, -Johns Hopkins University, -Baltimore, MD
*Purpose: Direct acting antivirals (DAAs) have led to high cure rates (>95%) for hepatitis C. Utilization of HCV+ donor kidneys for patients with advanced kidney…
2019 American Transplant Congress
Opioid Minimization in Kidney Transplant: Achievable Quicker Than You Think
J. N. Fleming, N. Patel, H. Gonzales, N. A. Pilch, S. Parks, C. Perez, P. K. Baliga, S. N. Nadig, D. J. Taber, V. Rohan
Medical University of South Carolina, Charleston, SC
*Purpose: Opioid use after kidney transplant has been shown to be a risk factor for chronic opioid use, which leads to an increased risk of…
2019 American Transplant Congress
Treg Suppressor Function within Allografts is Required for Tolerance
J. Ossart, A. Pena, H. Dai, L. Bauer, A. Williams, G. Camirand
Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: The role of regulatory CD4+Foxp3+ T cells (Treg) suppressor function within allografts in tolerance remains unclear. Thus, we sought to directly address: 1) whether…